PTC Therapeutics's total assets for Q1 2026 were $2.87B, a decrease of -1.45% from the previous quarter. PTCT total liabilities were $3.05B for the fiscal quarter, a -2.15% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.